Total Payments
$34,896
2024 Payments
$3,345
Companies
54
Transactions
1,073
Medicare Patients
9,162
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$24,231 (69.4%)
Research$4,311 (12.4%)
Travel$3,341 (9.6%)
Other$2,944 (8.4%)
Consulting$64.00 (0.2%)
Education$4.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,231 | 1,037 | 69.4% |
| Unspecified | $4,311 | 12 | 12.4% |
| Travel and Lodging | $3,341 | 19 | 9.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,913 | 2 | 8.3% |
| Consulting Fee | $64.00 | 1 | 0.2% |
| Entertainment | $30.71 | 1 | 0.1% |
| Education | $4.40 | 1 | 0.0% |
Payments by Type
General
$30,585
1,061 transactions
Research
$4,311
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $14,425 | 477 | $0 (2024) |
| Medtronic, Inc. | $5,065 | 147 | $0 (2024) |
| West-Ward Pharmaceuticals | $4,295 | 11 | $0 (2018) |
| Medtronic USA, Inc. | $2,323 | 54 | $0 (2020) |
| Boston Scientific Corporation | $1,907 | 85 | $0 (2024) |
| Curonix LLC | $1,072 | 9 | $0 (2024) |
| Vertiflex, Inc. | $837.28 | 24 | $0 (2019) |
| BIOTRONIK NRO, Inc. | $594.59 | 24 | $0 (2024) |
| Stimwave Technologies Incorporated | $365.26 | 4 | $0 (2021) |
| ABBVIE INC. | $292.37 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,345 | 82 | Curonix LLC ($991.93) |
| 2023 | $3,927 | 137 | Medtronic, Inc. ($2,843) |
| 2022 | $4,093 | 129 | Abbott Laboratories ($1,663) |
| 2021 | $2,501 | 132 | Abbott Laboratories ($1,181) |
| 2020 | $1,623 | 95 | Abbott Laboratories ($959.55) |
| 2019 | $4,830 | 137 | Abbott Laboratories ($2,214) |
| 2018 | $10,769 | 181 | Abbott Laboratories ($5,693) |
| 2017 | $3,807 | 180 | Abbott Laboratories ($1,852) |
All Payment Transactions
1,073 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $100.38 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $76.49 | General |
| 12/12/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $65.01 | General |
| Category: Neuromodulation | ||||||
| 12/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neuromodulation | ||||||
| 12/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Neuromodulation | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Medtronic, Inc. | ACCURIAN (Device) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 11/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neuromodulation | ||||||
| 11/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Neuromodulation | ||||||
| 11/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Neuromodulation | ||||||
| 11/08/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Not Applicable | ||||||
| 11/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $27.56 | General |
| Category: NEUROLOGY | ||||||
| 10/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Neurology | ||||||
| 10/10/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $8.68 | General |
| Category: Not Applicable | ||||||
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Neuromodulation | ||||||
| 09/11/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: PAIN | ||||||
| 08/30/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: Neuromodulation | ||||||
| 08/22/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $109.35 | General |
| Category: Neuromodulation | ||||||
| 08/22/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.25 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Opioid PMR Study | West-Ward Pharmaceuticals | $4,295 | 11 |
| ECAP Study | Saluda Medical Americas, Inc. | $16.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,062 | 7,421 | $1.7M | $305,799 |
| 2022 | 26 | 2,259 | 7,173 | $1.6M | $311,696 |
| 2021 | 28 | 2,266 | 9,206 | $1.7M | $337,566 |
| 2020 | 35 | 2,575 | 11,411 | $2.2M | $414,070 |
Total Patients
9,162
Total Services
35,211
Medicare Billing
$1.4M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 482 | 1,902 | $665,700 | $145,439 | 21.8% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 270 | 1,062 | $318,650 | $35,489 | 11.1% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 290 | 292 | $145,800 | $32,498 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 245 | $110,250 | $23,273 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $95,200 | $16,689 | 17.5% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 36 | 46 | $69,000 | $10,808 | 15.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 26 | 37 | $37,000 | $8,627 | 23.3% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 21 | 70 | $70,000 | $5,788 | 8.3% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 26 | 37 | $22,200 | $4,367 | 19.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 21 | 69 | $13,800 | $3,568 | 25.9% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 22 | 32 | $8,000 | $3,444 | 43.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 82 | 266 | $19,950 | $3,244 | 16.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 43 | 60 | $12,000 | $2,750 | 22.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 32 | $24,000 | $2,030 | 8.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 21 | 27 | $9,450 | $1,698 | 18.0% |
| 62367 | Electronic analysis of spinal canal drug infusion pump | Office | 2023 | 18 | 49 | $14,700 | $1,339 | 9.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 14 | $6,550 | $1,261 | 19.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 11 | 13 | $19,500 | $1,009 | 5.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $1,445 | $843.03 | 58.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 68 | 633 | $15,825 | $537.06 | 3.4% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 13 | 31 | $10,850 | $490.37 | 4.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 82 | 1,068 | $10,680 | $452.62 | 4.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 45 | 845 | $1,690 | $82.24 | 4.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 42 | 264 | $2,640 | $31.05 | 1.2% |
| J3010 | Injection, fentanyl citrate, 0.1 mg | Office | 2023 | 29 | 33 | $825.00 | $23.26 | 2.8% |
About Dr. Dharmesh Mehta, MD
Dr. Dharmesh Mehta, MD is a Pain Medicine healthcare provider based in Covina, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114980760.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dharmesh Mehta, MD has received a total of $34,896 in payments from pharmaceutical and medical device companies, with $3,345 received in 2024. These payments were reported across 1,073 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($24,231).
As a Medicare-enrolled provider, Mehta has provided services to 9,162 Medicare beneficiaries, totaling 35,211 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location Covina, CA
- Active Since 04/06/2006
- Last Updated 05/03/2024
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1114980760
Products in Payments
- Proclaim Family of SCS IPGs (Device) $4,620
- INTELLIS ADAPTIVESTIM (Device) $2,875
- Oxymorphone hydrochloride ER tablet (Drug) $2,507
- VANTA ADAPTIVESTIM (Device) $1,749
- PROCLAIM (Device) $1,651
- Morphine Sulfate ER tablets (Drug) $1,578
- SCS IPGs (Device) $1,190
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $1,072
- Proclaim IPG (Device) $958.66
- INTELLIS (Device) $906.02
- Superion ISS (Device) $837.28
- Penta SCS Leads (Device) $556.60
- RESTORE (Device) $499.29
- Amitiza (Drug) $460.19
- GENERAL PAIN MANAGEMENT (Device) $441.80
- ETERNA (Device) $411.48
- DRG leads (Device) $403.30
- Octrode SCS Leads (Device) $391.72
- Superion (Device) $378.05
- Superion Indirect Decompression System (Device) $375.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.